# Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children

> **NCT02515201** · PHASE4 · UNKNOWN · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 20 (estimated)

## Conditions studied

- Catheter-Related Infections

## Interventions

- **DRUG:** Taurolidine
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT02515201
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-03
- **Final completion:** 2016-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02515201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02515201, "Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02515201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*